Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis–Menten pharmacokinetic model

Abstract

BackgroundLittle is known about the population pharmacokinetics (PPK) of tacrolimus (TAC) in pediatric primary nephrotic syndrome (PNS). This study aimed to compare the predictive performance between nonlinear and linear PK models and investigate the significant factors of TAC PK characteristics in pediatric PNS. MethodsData were obtained from 71 pediatric patients with PNS, along with 525 TAC trough concentrations at steady state. The demographic, medical, and treatment details were collected. Genetic polymorphisms of CYP3A4*1G, CYP3A5*3, and ABCB1-C3435T were analyzed. The PPK models were developed using nonlinear mixed-effects model (NONMEM ® ) software. Two modeling strategies, linear compartmental and nonlinear Michaelis-Menten (MM) models, were evaluated and compared. ResultsBody weight, age, daily dose of TAC, co-therapy drugs (including azole antifungal agents and diltiazem), and CYP3A5*3 genotype were important factors in the final linear model (one-compartment model), whereas only body weight, co-therapy drugs, and CYP3A5*3 genotype were the important factors in the nonlinear MM model. Apparent clearance and volume of distribution in the final linear model were 7.13 L/h and 142 L, respectively.The maximal dose rate (Vmax) of the nonlinear MM model was 1.92 mg/day and the average concentration at steady state at half-Vmax (Km) was 1.98 ng/mL. The nonlinear model described the data better than the linear model.Dosing regimens were proposed based on the nonlinear PK model. ConclusionOur findings demonstrate that the nonlinear MM model showed better predictive performance than the linear compartmental model, providing reliable support for optimizing TAC dosing and adjustment in children with PNS.

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions

“…The variables inclusion forms of the previous study (Huang et al, 2019) were presented as follows, including continuous variables (Eqs. 11-13) and categorical variables (Eq.…”

Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies

“…In addition, in pediatric patients, age and body weight (BW) are supposed to significantly affect vancomycin PK. Therefore, a time‐dependent process of physical maturation was also considered 19,20 . Three models based on allometric scaling, including the maturation model (Eq.…”

“…In the forward inclusion analysis, inclusion criterion of the covariate in the model was a decrease in the objective function value (OFV) of greater than 3.84 (χ 2 test, p<0.05, df = 1). In the backward elimination step, the criterion for retaining covariate–parameter relationships was an increase in the OFV of greater than 6.63 (χ 2 test, p<0.01, df = 1).The covariates in the model were also selected based on the physiological plausibility of parameter estimates, goodness‐of‐fit plots, and statistical significance 20 …”

“…Therefore, a time-dependent process of physical maturation was also considered. 19,20 Three models based on allometric scaling, including the maturation model (Eq. 10), BW-dependent exponent model (Eq.…”

“…In the backward elimination step, the criterion for retaining covariate-parameter relationships was an increase in the OFV of greater than 6.63 (χ 2 test, p<0.01, df = 1).The covariates in the model were also selected based on the physiological plausibility of parameter estimates, goodness-offit plots, and statistical significance. 20…”